The Controlled Substances Act (CSA) is the foundation of U.S. federal drug policy, establishing how substances are classified, regulated, and enforced across five scheduling categories based on medical value, abuse potential, and safety standards.
Under the CSA, drugs are assigned to Schedule I through Schedule V, with Schedule I reserved for substances deemed to have no currently accepted medical use and a high potential for abuse, while lower schedules allow increasing levels of medical recognition and regulatory oversight.
At JRL CHARTS, we provide in-depth coverage of CSA-related developments, including marijuana rescheduling efforts, executive orders, DEA policy changes, congressional debates, and the impact of federal drug law on patients, veterans, healthcare systems, and LGBTQ+ communities.
This tag archives authoritative reporting on how the Controlled Substances Act continues to evolve — and how those changes affect medical access, public health, and national drug policy.
Related Coverage Links on JRL CHARTS:
• Get the Latest in LGBT Politics USA Exclusively on JRL CHARTS
• Where LGBTQ Texans Can Find Safety, Support, and Advocacy Resources
• Texas Passes THC Hemp Ban Amid Medical Marijuana Expansion
• Sexy Pot Marijuana-Shaped Massager is a Must Stock
• Black People Respond Worse to Marijuana Due to Their ‘Genetics’, Says GOP Lawmaker
Media Partners: For licensing inquiries, media usage rights, or republication requests, please visit our Contact Us page. All content © JRL CHARTS Media Network. Unauthorized use is strictly prohibited.
